Article

Aryl N-acetamide compounds exert antimalarial activity by acting as agonists of rhomboid…

medRxiv · 2025 · Boulet, C.; Modak, J. K.; Counihan, N. A.; Parkyn Schneider, M.; Nguyen, W.; Dans, M. G.; Barnes, C. B. G.; Razook, Z.; McCann, k.; Barry, A. E.; Crabb, B. S.; de Koning-Ward, T. F.; Gilson, P. R.

Key facts

Title Aryl N-acetamide compounds exert antimalarial activity by acting as agonists of rhomboid protease PfROM8 and cation channel PfCSC1.
First author Boulet, C.; Modak, J. K.; Counihan, N. A.; Parkyn Schneider, M.; Nguyen, W.; Dans, M. G.; Barnes, C. B. G.; Razook, Z.; McCann, k.; Barry, A. E.; Crabb, B. S.; de Koning-Ward, T. F.; Gilson, P. R.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.03.18.644039
Devices mentioned K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967, K923274 and 10 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, JJH

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature